Ann: Michael J Fox grant for Parkinson's research on ATH434, page-15

Thanks, Olzard, I like this insider information. Who would know more than they about a company not giving too much info to us normal investor. They for sure know more than we. They know for example how the deals about PBT2 are progressing, not in detail but more than we. Insiders have bought around 400M ordinary shares. Today there was some more, perhaps, up 7% with reasonable volume with no news, typical to insiders perhaps (?) to buy at this time.
The number of insiders must be quite small in this kind of a small company with 12 full-time employees. Of course, there are more insiders than 12 but in any case, the number of insiders must be quite small.
The insiders know also what else might be cocking and what perhaps will be informed us in few weeks. There will be in April the virtual American Academy of Neurology meeting, starting on the 17th of April. Last year ATH had 2 posters there. It is a good forum to tell some news if they want. The abstracts have been sent already by now and the insiders know what is on them. But there may be something else the insiders know.